In a bid to bring down the cost of insulin, California under Gov. Gavin Newsom inked a contract to produce the drug. It's ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

Unfortunately, the current drug pricing bill fails to take a holistic ... The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog ...

adjust dosage according to latest SMBG value. U-500 has prandial and basal time–action profile characteristics. d Basal insulin (glargine, detemir, or isophane [NPH]) may be substituted for ...

These medications were sitagliptin, liraglutide, glimepiride, or insulin glargine U-100. Sitagliptin, liraglutide, and ...

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo ... They will use drug substance made by GeneSys Biologics but will be made at Civica's ...

If your body cannot make or use insulin effectively, you need to inject it to process your food for energy. Calculating a bolus dose is where insulin administration can get tricky. When you give y ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a newer class of drugs used to treat diabetes, have recently been ...

She adds that decisions regarding insulin dosing should be made together with your medical provider to avoid dangerous high or low blood sugars. Though it can be a cost-effective option ...

Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar ...

This table may help to avoid unnecessary drug loss and expenditures due to ... 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi ...